Form 4: Disc Medicine Director Sells Shares
Insider Transaction (Form 4)
Kevin Bitterman, a Director of Disc Medicine, Inc., sold 1,689 shares of common stock on September 4, 2026 for $79.96 per share.
Summary
- Open-market sale: disposed of 912 Common Stock at $79.96 ($72,924) on September 4, 2026; holds 318,866 after (Indirect).
- Open-market sale: disposed of 759 Common Stock at $79.96 ($60,690) on September 4, 2026; holds 312,230 after (Indirect).
- Open-market sale: disposed of 18 Common Stock at $79.96 ($1,439) on September 4, 2026; holds 13,427 after (Indirect).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $135,052 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Kevin Bitterman — Director
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-04 | Open-market sale | Common Stock | 912 | $80 | $72.9K | 318,866 |
| 2026-09-04 | Open-market sale | Common Stock | 759 | $80 | $60.7K | 312,230 |
| 2026-09-04 | Open-market sale | Common Stock | 18 | $80 | $1.4K | 13,427 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-04 | Open-market sale (912 shares) |
| 2026-09-04 | Open-market sale (759 shares) |
| 2026-09-04 | Open-market sale (18 shares) |
Keywords
insider transaction, Form 4, IRON, Disc Medicine, Inc., bearish, Kevin Bitterman
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.